Daniel J. Lippis insider trades: Edwards Lifesciences (EW) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | EW | ↓ Sell | 619 | $85.65 | $53K | Direct | Oct 8, 2026 (0d) |
| Sep 11, 2026 | EW | ↓ Sell | 1,238 | $87.51 | $108K | Direct | Sep 11, 2026 (0d) |
| Aug 11, 2026 | EW | ↓ Sell | 619 | $92.03 | $57K | Direct | Aug 11, 2026 (0d) |
| Jul 10, 2026 | EW | ↓ Sell | 619 | $91.70 | $57K | Direct | Jul 10, 2026 (0d) |
| Jun 30, 2026 | EW | ↓ Sell | 619 | $91.40 | $57K | Direct | Jun 30, 2026 (0d) |
| May 4, 2026 | EW | ↓ Sell | 2,038 | $83.49 | $170K | Direct | May 4, 2026 (0d) |
| Apr 6, 2026 | EW | ↓ Sell | 1,019 | $80.98 | $83K | Direct | Apr 6, 2026 (0d) |
| Dec 12, 2025 | EW | ↓ Sell | 1,019 | $84.03 | $86K | Direct | Dec 12, 2025 (0d) |
| Nov 10, 2025 | EW | ↓ Sell | 1,020 | $82.55 | $84K | Direct | Nov 10, 2025 (0d) |
| Jul 28, 2025 | EW | ↓ Sell | 4,114 | $79.46 | $327K | Direct | Jul 28, 2025 (0d) |
| May 9, 2025 | EW | ↓ Sell | 330 | $74.42 | $25K | Direct | May 9, 2025 (0d) |
| Apr 8, 2025 | EW | ↓ Sell | 300 | $70.61 | $21K | Direct | Apr 8, 2025 (0d) |
| Mar 10, 2025 | EW | ↓ Sell | 400 | $69.48 | $28K | Direct | Mar 10, 2025 (0d) |
| Feb 13, 2025 | EW | ↓ Sell | 500 | $76.34 | $38K | Direct | Feb 13, 2025 (0d) |
| Jan 16, 2025 | EW | ↓ Sell | 500 | $68.76 | $34K | Direct | Jan 16, 2025 (0d) |
| Dec 16, 2024 | EW | ↓ Sell | 2,500 | $74.08 | $185K | Direct | Dec 16, 2024 (0d) |
| Jul 11, 2024 | EW | ↓ Sell | 500 | $94.18 | $47K | Direct | Jul 11, 2024 (0d) |
| Jun 20, 2024 | EW | ↓ Sell | 535 | $90.00 | $48K | Direct | Jun 20, 2024 (0d) |
| May 7, 2024 | EW | ↓ Sell | 857 | $85.60 | $73K | Direct | May 9, 2024 (2d) |
| Apr 9, 2024 | EW | ↓ Sell | 857 | $92.34 | $79K | Direct | Apr 9, 2024 (0d) |
| Mar 7, 2024 | EW | ↓ Sell | 1,715 | $90.98 | $156K | Direct | Mar 7, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EW insiders
Open-market trades in the last 12 months
About Daniel J. Lippis's insider trades
Daniel J. Lippis is Cvp, Tavr at Edwards Lifesciences (EW). Since Mar 7, 2024, Daniel has reported no open-market purchases and 21 sales worth $1.8M on SEC Form 4. In the last 12 months: 9 sales ($754K).
Their filings also include option exercises (20 filings), shares withheld for taxes (15 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EW insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.